Page 1 | Search Results | Archives of Pathology & Laboratory Medicine

Skip to Main Content

Skip Nav Destination

1-3 of 3

Sort by

Sort Order Select

Journal Articles

Pan-Cancer Biomarkers: Changing the Landscape of Molecular Testing

Jinjuan Yao, MD, PhD, Maria E. Arcila, MD, Marc Ladanyi, MD, PhD, Jaclyn F. Hechtman, MD

Arch Pathol Lab Med (2020) 145 (6): 692–698.

https://doi.org/10.5858/arpa.2020-0513-RA

Published: 29 December 2020

View article titled, Pan-Cancer Biomarkers: Changing the Landscape of Molecular Testing

Journal Articles

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

Neal I. Lindeman, MD, Philip T. Cagle, MD, Dara L. Aisner, MD, PhD, Maria E. Arcila, MD, Mary Beth Beasley, MD ...

Arch Pathol Lab Med (2018) 142 (3): 321–346.

https://doi.org/10.5858/arpa.2017-0388-CP

Published: 22 January 2018

View article titled, Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

Includes: Supplementary data

Journal Articles

Optimizing Workflows and Processing of Cytologic Samples for Comprehensive Analysis by Next-Generation Sequencing: Memorial Sloan Kettering Cancer Center Experience

Shaozhou Ken Tian, MD, J. Keith Killian, MD, PhD, Natasha Rekhtman, MD, PhD, Ryma Benayed, PhD, Sumit Middha, PhD ...

Arch Pathol Lab Med (2016) 140 (11): 1200–1205.

https://doi.org/10.5858/arpa.2016-0108-RA

Published: 02 September 2016

View article titled, Optimizing Workflows and Processing of Cytologic Samples for Comprehensive Analysis by Next-Generation Sequencing: Memorial Sloan Kettering Cancer Center Experience